149 related articles for article (PubMed ID: 3928906)
1. Thiotepa effects on urinary cytology in the interpretation of transitional cell cancer.
Droller MJ; Erozan YS
J Urol; 1985 Oct; 134(4):671-4. PubMed ID: 3928906
[TBL] [Abstract][Full Text] [Related]
2. Intensive intravesical chemotherapy in the treatment of flat carcinoma in situ: is it safe?
Droller MJ; Walsh PC
J Urol; 1985 Dec; 134(6):1115-7. PubMed ID: 3932686
[TBL] [Abstract][Full Text] [Related]
3. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma.
Soloway MS; Jordan AM; Murphy WM
Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268
[TBL] [Abstract][Full Text] [Related]
4. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
[TBL] [Abstract][Full Text] [Related]
5. The effect of intravesical thio-tepa on normal and tumor urothelium.
Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
[TBL] [Abstract][Full Text] [Related]
6. The FISH test for the diagnosis, surveillance, and prognosis of transitional cell carcinoma of the bladder.
Haddad FS
J Med Liban; 2008; 56(4):230-2. PubMed ID: 19115598
[TBL] [Abstract][Full Text] [Related]
7. [Effects of intravesical instillation of antitumor agents on bladder cancer].
Tomiyama T
Nihon Hinyokika Gakkai Zasshi; 1972 Jul; 63(7):497-518. PubMed ID: 4628074
[No Abstract] [Full Text] [Related]
8. Effect of different local and systemic therapy upon urinary bladder cytology.
Borgmann V; al-Abadi H; Friedrichs R; Nagel R
Urol Int; 1993; 50(1):21-6. PubMed ID: 8434422
[TBL] [Abstract][Full Text] [Related]
9. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
10. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer.
Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800
[TBL] [Abstract][Full Text] [Related]
11. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
Nissenkorn I; Servadio C; Vilikowski E; Glanz I
J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
[TBL] [Abstract][Full Text] [Related]
12. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
Nieh PT; Daly JJ; Irwin RJ; Prout GR
Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic adenoma in patients with transitional cell carcinoma of the bladder receiving intravesical thiotepa.
Wood DP; Streem SB; Levin HS
J Urol; 1988 Jan; 139(1):130-1. PubMed ID: 3121867
[TBL] [Abstract][Full Text] [Related]
14. Intravesical chemotherapy for superficial carcinoma of the bladder.
Foo KT; Tan EC; Tung KH; Tock EP
Singapore Med J; 1991 Dec; 32(6):420-2. PubMed ID: 1788600
[TBL] [Abstract][Full Text] [Related]
15. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
Horn Y; Eidelman A; Walach N; Ilian M
J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
[No Abstract] [Full Text] [Related]
16. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer.
Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P
J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041
[TBL] [Abstract][Full Text] [Related]
17. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
Soloway MS
J Urol; 1980 Apr; 123(4):461-6. PubMed ID: 6767860
[No Abstract] [Full Text] [Related]
18. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
19. Introduction and overview of intravesical therapy for superficial bladder cancer.
Soloway MS
Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
[TBL] [Abstract][Full Text] [Related]
20. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
Rampal M; Alimi JC; Pons G; Fiquet JM
J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
[No Abstract] [Full Text] [Related]
[Next] [New Search]
